Delivery Order SPE2DB22D2211-SPE2DB23FPBL7
Award Date 8/29/23
Potential Completion Date 8/30/23
Potential Value $19
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $9,910 delivery order to Amerisourcebergen Drug Corporation for methotrexate in 1 gram/40 ml vials. The firm fixed price order is for 40 ml vials of the chemotherapy drug to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania and will be completed by June 23, 2023. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, this order for methotrexate is consistent with the Defense Logistics Agency's...
- The Defense Logistics Agency awarded a $69,370 delivery order to Amerisourcebergen Drug Corporation for methotrexate in 1 gram/40 ml vials. The firm fixed price order is for 40 ml vials of the chemotherapy drug to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania and will be completed by July 26, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for methotrexate will support the DLA's mission to provide...
- The Defense Logistics Agency awarded a $37,760 delivery order to Amerisourcebergen Drug Corporation for methotrexate injections. The firm fixed price order is for the delivery of 4562252108 units of methotrexate at 50 mg/2 ml per vial with a total of 2 ml per vial. Performance will take place at Amerisourcebergen's facility located in Conshohocken, Pennsylvania between September 20-21, 2023. As a major provider of pharmaceuticals and medical supplies to the U.S. military and other government...
- The Defense Logistics Agency awarded a $18,880 firm fixed price delivery order to Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, to provide 50 mg/2 ml vials of the pharmaceutical methotrexate. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from August 29 to August 30, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for the chemotherapy drug...
- The Defense Logistics Agency awarded a $18,880 delivery order to Amerisourcebergen Drug Corporation for 4561422305, methotrexate 50 mg/2 ml vials. The firm fixed price order is for delivery of the pharmaceutical product to a location in Conshohocken, Pennsylvania, with performance required from July 6-7, 2023. As a major distributor of pharmaceuticals and medical supplies for the Department of Defense, this order for methotrexate, a chemotherapy and anti-inflammatory drug, is consistent with the...
- The Defense Logistics Agency Troop Support Medical awarded a $18,880 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561323709 methotrexate 50 mg/2 ml vials. The delivery order was issued against an indefinite-delivery/indefinite-quantity contract vehicle and calls for the delivery of 2 ml vials of methotrexate to a facility in Conshohocken, Pennsylvania. The period of performance is June 23, 2023 through June 26, 2023. No subcontractors or set aside...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $18,880 to Amerisourcebergen Drug Corporation for the supply of 4561821700 METHOTREXATE 50 MG/2 ML VIAL 2ML. Performance will take place in Conshohocken, Pennsylvania over a period of one day, from August 15 to August 16, 2023. As a major distributor of pharmaceuticals and medical supplies, Amerisourcebergen will deliver the requested methotrexate vials to support the Defense Logistics Agency's stockpile of...
- The Defense Logistics Agency awarded a $21,080 delivery order to Amerisourcebergen Drug Corporation for methotrexate injection vials. Under the firm fixed price contract, Amerisourcebergen will provide 4561781216 units of 50 mg/2 mL methotrexate in 2 mL vials to the DLA from its facility in Conshohocken, Pennsylvania. The order period of performance is August 11-14, 2023. As a major supplier of pharmaceuticals to the Department of Defense, this award supports the DLA's mission to provide medical...
- The Defense Logistics Agency awarded a $18,880 delivery order to Amerisourcebergen Drug Corporation for the provision of 4561881678 methotrexate 50 mg/2 ml vials. The firm fixed price order is for 2 ml vials of the drug and will be fulfilled by Amerisourcebergen from its facility located in Conshohocken, Pennsylvania. The single day order was placed under an existing DLA pharmaceuticals contract vehicle and supports the Agency's medical supply needs. No set aside designation or subcontractors...
- The Defense Logistics Agency awarded a $18,880 delivery order to Amerisourcebergen Drug Corporation for methotrexate 50 mg/2 ml vials. The firm fixed price order is for a one day period of performance from September 18-19, 2023. Amerisourcebergen will fulfill the order from its facility located in Conshohocken, Pennsylvania. The Defense Logistics Agency manages the Department of Defense's global supply chain and is likely procuring the methotrexate to support treatment of certain cancers or...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB23FPBL7Delivery Order
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $18,880 to Amerisourcebergen Drug Corporation for the supply of 4561986295 units of methotrexate at 50 mg/2 ml per vial with 2 ml volume. Performance will occur at Amerisourcebergen's facility located in Conshohocken, Pennsylvania over a one day period from August 29, 2023 through August 30, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for the chemotherapy drug methotrexate supports the Agency's mission to provide critical healthcare resources to military members. No subcontractors or set aside designations were identified in the award information.
Generated 12/19/23, 10:09 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19 | 8/29/23 |